Preoperative Soy Isoflavone Supplementation in the Prevention of Head and Neck Squamous Carcinoma

2014-08-27 03:17:26 | BioPortfolio


We hypothesize that p16 hypermethylation in tumor and adjacent non-tumor mucosa identifies patients who have impaired response to stress signals associated with smoking, and that p16 hypermethylation and associated over expression of downstream targets such as COX-2, VEGF, EGFR and IL6 can be abrogated by soy isoflavone supplementation.


The overall long term goal of the proposed research is to determine if administration of a soy isoflavone will provide a basis for secondary prevention and cancer control that can decrease tumor recurrence and increase overall survival and quality of life in patients with head and neck squamous carcinoma. Secondarily, we hope to identify candidate genes and intermediate endpoints for future primary prevention trials. The inclusion of Karmanos Cancer Institute and Emory University will provide additional new patient accrual and improved access to minority patients.

We will conduct a Phase II trial to determine whether short term (3 weeks) soy isoflavone administration can modulate p16 methylation and tissue expression of p53, p16, EGFR, VEGF, Bcl-xL and COX-2 in resected specimens and adjacent non-tumor mucosa to potentially identify markers useful as intermediate endpoints and define how quickly changes in gene markers might be seen. Correlation of pretreatment tissue markers with serum and saliva markers will be determined to identify potential surrogates of tissue markers that could be useful in serial monitoring protocols in patients or high risk populations with oral leukoplakia or dysplasia where serial tumor specimens are not available. This protocol is designed to provide a comprehensive assessment of adjuvant soy isoflavone and molecular markers in a prospective clinical trial setting. Accrual will be enhanced by the addition of Karmanos Cancer Institute and Emory University.

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Squamous Carcinoma


Soy Isoflavone


University of Michigan Health System
Ann Arbor
United States




University of Michigan Cancer Center

Results (where available)

View Results


Published on BioPortfolio: 2014-08-27T03:17:26-0400

Clinical Trials [1572 Associated Clinical Trials listed on BioPortfolio]

The Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women

Climacterium is marked by hypoestrogenism and it is associated to drastic vasomotors symptoms, genital atrophy and humor alteration. Additionally, these symptoms impair sexual life and lif...

Investigation of Desmoplastic Squamous Cell Carcinoma

Aim of the study is to verify wether it is possible to have a more sensitive diagnostic tool using pancytokeratin immunohistochemistry for desmoplastic squamous cell carcinoma compared to ...

Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

The purpose of this study is to assess the efficacy and safety of pembrolizumab in patient with locally advanced or metastatic squamous cell carcinoma of the skin

Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

The purpose of this study is to further test a combination chemotherapy regimen for the treatment of squamous cell carcinoma of the head and neck and to see if the addition of supportive m...

MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of the Head and Neck (SCCHN) is a devastating illness, the treatment of which is associated with significant morbidity. This type of cancer affects 43,000 individua...

PubMed Articles [3423 Associated PubMed Articles listed on BioPortfolio]

Comparison of Anal Versus Rectal Staging in the Prognostication of Rectal Squamous Cell Carcinoma: A Population-Based Analysis.

Rectal squamous cell carcinoma is a rare malignancy with limited data regarding management and prognosis. It is also unknown whether a rectal squamous cell cancer staging system should be based on siz...

Narrow-band imaging detects synchronous oropharyngeal squamous carcinoma during treatment of an early esophageal squamous cell carcinoma.

Combination of serum squamous cell carcinoma antigens 1 and 2 as potential diagnostic marker for sinonasal squamous cell carcinoma and inverted papilloma.

Differentiating inverted papilloma from squamous cell carcinoma (SCC) is sometimes difficult. We evaluated the clinical usefulness of serum SCCA1 and SCCA2 in the management of patients with inverted ...

Squamous cell carcinoma arising in a sacrococcygeal tailgut cyst.

We report a case of squamous cell carcinoma originated from a sacrococcygeal tailgut cyst in a 73-year-old female patient. Tailgut cysts are generally multilocal and have a layer of either columnar, s...

Poorly differentiated plasmacytoid squamous cell carcinoma: Case report of a rare malignancy.

Plasmacytoid squamous cell carcinoma is an especially aggressive variant of squamous cell carcinoma that has previously been described in the literature as a variant of oral cancers and most extensive...

Medical and Biotech [MESH] Definitions

A carcinoma derived from stratified squamous epithelium. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.

A skin carcinoma that histologically exhibits both basal and squamous elements. (From Dorland, 27th ed)

A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.

Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males.

More From BioPortfolio on "Preoperative Soy Isoflavone Supplementation in the Prevention of Head and Neck Squamous Carcinoma"

Quick Search


Relevant Topics

Stress is caused by your perception of situations around you and then the reaction of your body to them. The automatic stress response to unexpected events is known as 'fight or flight'. Discovered by Walter Cannon in 1932, it is the release of h...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Searches Linking to this Trial